Friday, Oct 25, 2024 · SEC filings

What the smart money revealed on Oct 25

Real insider buys25insiders · $9.08M
Real insider sales33insiders · $47.5M
Fund 13Fs filed—not loaded for this day
Activist 13Ds filed—not loaded for this day

246 insider filings came in. We hid 26 planned (10b5-1) sellers and 138 people whose filings were routine, like grants and tax withholding.

group

5 insiders at Ingram Micro Holding (INGM) bought $7.04M of stock

Roles: CEO, CFO, CAO, Executive VP, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Oct 25
$7.04M
group

4 insiders at Sixth Street Lending Partners bought $728K of stock

Roles: Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Mar 6–Sep 24
$728K
group

4 insiders at High Roller Technologies (ROLR) bought $570K of stock

Roles: CEO, Director. Several insiders buying in the same few days is rare.

Cluster buy Form 4 Traded Oct 23
$570K
trending_up

Norfolk Southern (NSC) Director Richard Anderson bought $258K

1,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Oct 24
$258K
trending_up

Norfolk Southern (NSC) Director Sameh Fahmy bought $255K

1,000 shares on the open market. Not a grant or an option exercise. Their past buys: 4 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 4 of 4 beat Traded Oct 24
$255K
trending_up

Central Securities (CET) Vice President Andrew O'Neill bought $62.4K

1,354 shares on the open market. Not a grant or an option exercise. Their past buys: 3 of 4 checked quarters beat the typical stock 6 months later.

Real buy Form 4 Past buys: 3 of 4 beat Traded Oct 24
$62.4K
trending_up

Viatris (VTRS) Director Harry Korman bought $61.3K

Open-market buys of more than one share class. Not a grant or an option exercise.

Real buy Form 4 Traded Dec 11–Oct 26
$61.3K
trending_down

Philip Morris International (PM) Director Andre Calantzopoulos sold $13.2M

Not marked as a planned 10b5-1 sale. Sold 10% of the shares they held directly. Still holds 959,761 shares.

Real sale Form 4 Traded Oct 23
$13.2M
trending_down

Wyndham Hotels & Resorts (WH) Director Stephen Holmes sold $7.28M

Not marked as a planned 10b5-1 sale. Sold 18% of the shares they held directly. Still holds 366,371 shares.

Real sale Form 4 Traded Oct 25
$7.28M
trending_down

Wyndham Hotels & Resorts (WH) CFO and Head of Strategy Michele Allen sold $1.35M

Not marked as a planned 10b5-1 sale. Sold 60% of the shares they held directly. Still holds 10,056 shares.

Real sale Form 4 Sold 60% of stake Traded Oct 25
$1.35M
Show 8 more real buys
Show 30 more real sales
TNL Travel & Leisure · Director Stephen Holmes · Traded Oct 25
$3.8M
HLT Hilton Worldwide · Officer Michael Duffy · Traded Oct 24
$3.38M
PM Philip Morris International · Pr SSEA CIS and MEA Region Frederic De Wilde · Traded Oct 23
$3.27M
LAD Lithia Motors · COO Chris Holzshu · Traded Oct 24
$2.86M
WMT Walmart · President and CEO C. Douglas McMillon · Traded Oct 24
$2.41M
WH Wyndham Hotels & Resorts · Chief Accounting Officer Nicola Rossi · Traded Oct 25
$2.31M
PG Procter & Gamble · Chief Human Resources Officer Balaji Purushothaman · Traded Oct 24
$2.16M
PM Philip Morris International · Pr.Combusibles&GlobalComb.Mktg Werner Barth · Traded Oct 23
$975K
EFOR ASGN · President Randolph Blazer · Traded Oct 25
$950K
HRI Herc · Director Michael Kelly · Traded Oct 24
$810K
TRV Travelers Companies · Vice Chairman William Heyman · Traded Oct 24
$524K
CMA Comerica · Executive Vice President James Weber · Traded Oct 24
$411K
VLGEA Village Super Market · Director Kevin Begley · Traded Oct 23–25
$279K
CRTO Criteo S.A. · CFO Sarah Glickman · Traded Oct 23
$221K
WTFC Wintrust Financial · CFO David Stoehr · Traded Oct 24
$182K
TRAK ReposiTrak · CEO Randall Fields · Traded Oct 23–24
$144K
SIGI Selective Insurance Group · SVP Anthony Harnett · Traded Oct 25
$130K
IMVT Immunovant · Chief Legal Officer Mark Levine · Traded Oct 23
$129K
PKBK Parke Bancorp · Director Daniel Dalton · Traded Oct 24
$105K
EFOR ASGN · Director Carol Lindstrom · Traded Oct 25
$98.6K
TWST Twist Bioscience · President and COO Patrick Finn · Traded Oct 23
$97.4K
IMVT Immunovant · Chief Medical Officer Michael Geffner · Traded Oct 23
$94.2K
IMVT Immunovant · CTO Jay Stout · Traded Oct 23
$80.9K
SYM Symbotic · Officer Michael Dunn · Traded Oct 24
$49.3K
FPH Five Point · Director William Browning · Traded Oct 24
$44.7K
ALGT Allegiant Travel · COO Keny Wilper · Traded Oct 23
$39.8K
PEBO Peoples Bancorp · Director David Dierker · Traded Oct 24
$31K
APRE Aprea Therapeutics · Director Marc Duey · Traded Oct 18
$29.6K
PNTG Pennant Group · Director JoAnne Stringfield · Traded Oct 23
$12.8K
HYMC Hycroft Mining Holding · Executive Vice President and CFO Stanton Rideout · Traded Oct 23
$3.17K

13F season

Holdings as of Sep 30, 2024 are due Nov 14

58 funds have filed so far. 54 filed for the quarter before.

Biggest real insider buys, Oct 19–25

Open-market buys by officers and directors, filed in the 7 days up to Oct 25.

Where this data comes from. Insider trades, fund holdings, activist stakes and company results come from public SEC EDGAR filings (Forms 4, 13F, 13D/13G, 10-Q and 8-K). Congress trades come from the STOCK Act reports members file with the House Clerk and the Senate. Daily closing prices come from post-no-preference/stocks on DoltHub, a community-run database shared under CC BY-SA 4.0; the prices we show stay under that license. They are each day's close, not live or official exchange prices.

This is data, not investment advice. About StockToast · Your watchlist